Formulated as a cream with cetyl alcohol and other excipients. Local skin reactions (edema, erythema/redness, skin atrophy, stinging/burning, striae rubrea, telangiectasia) were observed during a treatment period with clascoterone cream, and occurred in a similar percentage of subjects treated with the vehicle cream.
Skip to main content
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAME: Winlevi (Cassiopea)
- INDICATIONS: Topical treatment of acne vulgaris
- SYNONYM: Cortexolone 17α-propionate
- CLASS: Androgen receptor inhibitor
- HALF-LIFE: Excretion of clascoterone has not been fully characterised in humans.
- FDA APPROVAL DATE: 08/26/2020
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
No clinical studies evaluating the drug interaction potential of clascoterone (cream) have been conducted. - PREGNANCY: No available data to assess drug-associated risk of clascoterone in pregnant women.
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 04/18/2026
